Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Trademark Information
Application ID
Status
Sub Status
Not Applicable
Date of Application
09 November 2020
Classes
99
Proprietor
The Surrey Research Park, 2 Occam Court, Guildford, Surrey, United Kingdom
Agent
Anand And Anand.[295]
B 41,Nizamuddin East, New Delhi 110 013.
Type
Word
State
Delhi
Country
Filing Mode
e-Filing
IP Office
DELHI
Used Since
Valid / Upto
Description
[Class : 9] Downloadable Software For Data Conversion, Integration, Visualization And Analysis In The Field Of Pharmaceutical And Biotherapeutic Research, Development And Manufacturing; Downloadable Software For Integration Of Research, Development, And Manufacturing Processes And Analytical Instrumentation, Equipment And Data In The Field Of Pharmaceutical And Biotherapeutic Research, Development And Manufacturing; Downloadable Software For Scientific Process Management, Experiment Process And Batch Execution, Scheduling And Resource Management; Downloadable Software For Product Formulation And Recipe Management, And Transfer Of Process, Recipe And Associated Data From Product Development To Product Manufacturing, All In The Field Of Pharmaceutical And Biotherapeutic Research, Development And Manufacturing; Downloadable Software For Bioprocess Modelling And Simulation And In Silico Process Development, For Use In Bioprocess Characterization And Optimization, In The Field Of Pharmaceutical And Biotherapeutic Research, Development And Manufacturing, In Class 9. [Class : 42] Software As A Service (Saa S) For Data Conversion, Integration, Visualization And Analysis In The Field Of Pharmaceutical And Biotherapeutic Research, Development And Manufacturing; Software As A Service (Saa S) For Integration Of Research, Development, And Manufacturing Processes And Analytical Instrumentation, Equipment And Data In The Field Of Pharmaceutical And Biotherapeutic Research, Development And Manufacturing; Software As A Service (Saa S) For Scientific Process Management, Experiment Process And Batch Execution, Scheduling And Resource Management; Software As A Service (Saa S) For Product Formulation And Recipe Management, And Transfer Of Process, Recipe And Associated Data From Product Development To Product Manufacturing, All In The Field Of Pharmaceutical And Biotherapeutic Research, Development And Manufacturing; Software As A Service (Saa S) For Bioprocess Modelling And Simulation And In Silico Process Development, For Use In Bioprocess Characterisation And Optimisation, In The Field Of Pharmaceutical And Biotherapeutic Research, Development And Manufacturing, In Class 42.
Sign In to Follow Application
All Documents & Correspondence
All Documents & Correspondence
Uploaded Documents
| 1 | TM-A(MULTICLASS CONVENTION APPLICATION) | 09 Nov 2020 |
| 2 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 26 Nov 2020 |
| 3 | Priority Document | 25 Nov 2021 |
| 4 | Reply to Exam Report (MIS-R) | 17 Dec 2021 |
| 5 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 30 May 2023 |
| 6 | TM-O(NOTICE OF OPPOSITION) | 09 Oct 2023 |
| 7 | TM-O(NOTICE OF OPPOSITION) | 09 Oct 2023 |
| 8 | TM-O(NOTICE OF OPPOSITION) | 11 Oct 2023 |
| 9 | Journal Copy | 21 Oct 2023 |
| 10 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 11 Jan 2024 |
| 11 | Evidence Affidavit Under Rule 46 (TOP) | 30 May 2024 |
| 12 | Annexure -1 under rule 46 | 30 May 2024 |
| 12 | Evidence Affidavit Under Rule 46 (TOP) | 30 May 2024 |
| 13 | Annexure -1 under rule 46 | 30 May 2024 |
| 13 | Evidence Affidavit Under Rule 46 (TOP) | 30 May 2024 |
| 14 | Annexure -1 under rule 46 | 30 May 2024 |
Correspondence and Notices
| 1 | Hearing Notice (Show Cause) | 15151632 | 25 Apr 2023 | |
| 2 | Tribunal Accepted Notice for : 4737802 | 15352335 | 5985485 | 02 Jun 2023 |
| 3 | Opposition Notice | 16438389 | 6319876 | 03 Nov 2023 |
| 4 | Opposition Notice | 16438427 | 6319846 | 03 Nov 2023 |
| 5 | Opposition Notice | 16478594 | 6330526 | 07 Nov 2023 |
| 6 | Opposition Counter Statement | 17276150 | 6510195 | 01 Feb 2024 |
| 7 | Opposition Counter Statement | 17276234 | 6510229 | 01 Feb 2024 |